Skip to content
thispeptide

Remedy Meds

Remedy Meds combines compounded GLP-1 treatment, initial live clinical review and continuing messaging or video access. Its strong outcome and guarantee marketing needs to be read alongside the clinical, subscription and FDA record.

Review by Paul Hardy, standards editor · Updated October 2026

The short version

Remedy describes clinical access and names the professional groups. That does not establish a prescription’s quality or likely result. Obtain the clinician, pharmacy and treatment terms before joining, and give the FDA’s historical advertising findings appropriate weight.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

FDA warning letter on record: Letter 716830 · September 2025

Remedy Meds LLC operates a weight-care platform. Its homepage names compounded semaglutide and tirzepatide, each in injection form. It also describes microdosing and a brand-prescription pathway. The standard compounded program bundles medication supply with care access. A specific medicine and protocol still require clinical approval.

What Remedy Meds prescribes, by goal

Weight

  • SemaglutideFDA-approved
    • Injection (compounded)Price not published
  • TirzepatideFDA-approved
    • Injection (compounded)Price not published

The current homepage describes weekly compounded semaglutide and tirzepatide injections, as well as smaller-dose protocols and selected brands. A marketing comparison between those plans is not a personalized treatment recommendation. Compounded preparations are not FDA-approved. The prescriber should explain the formulation, risks, alternatives and reason for customization.

Who prescribes

A licensed clinician

The terms name OpenLoop Healthcare Partners, PC and JMP Medical, a professional association. The network also includes KMG Medical Group MO, a professional corporation, and their affiliates. Remedy’s company provides administration and technology, while those professional entities deliver medical care. The consent says a patient may see a nurse practitioner or physician assistant rather than a physician. Nonclinical support staff cannot supply medical advice. Ask which clinician and pharmacy will handle your treatment.

After an initial intake and payment, the service collects further medical information for assessment. You have a synchronous clinical consultation before any prescription is issued. Later refill reviews may be asynchronous unless the patient requests, or the clinician requires, another live session. The program describes unlimited clinician consultations and messaging, while refill forms collect progress and tolerability information. A membership can keep charging even when the patient does not complete a refill form or receive medication.

Are labs required?

Individual testing plan unconfirmed

The terms allow a clinician to request additional services, including laboratory testing, outside the program entitlement. The public pages reviewed do not establish the same baseline panel or one lab price for every patient. Confirm whether tests are needed and what is included before assuming a complete assessment has been covered.

Ready to start with Remedy Meds?

Prices and plans are set on the seller's own site.

What it claims, and what it cites

The homepage attributes weight-loss figures to self-reported member data and discloses compensated testimonials. Its comparison with published drug outcomes is not a randomized service trial. It cannot prove superiority over another clinic. The annual warranty has continuity, medication and reporting conditions. It does not promise an individual result. FDA warning letter CMS 716830, dated September 9, 2025, concerned Remedy’s August 2025 compounded semaglutide and tirzepatide claims. The agency said they misleadingly implied sameness with approved products. No FDA closeout was confirmed in this review. Current disclosures acknowledging the lack of FDA approval should not be mistaken for agency resolution of that letter.

How it bills

No universal cash subscription amount was established from the current public homepage and legal pages reviewed. The terms describe monthly and longer bundles paid upfront. They renew automatically and require advance cancellation notice. A four-week medicine supply and the warranty’s thirteen-shipment condition do not by themselves establish thirteen yearly subscription charges. The standard program includes care and compounded supply, but additional clinical services may be outside the entitlement. Get a written price and the exact renewal schedule before entering an agreement.

For and against

  • For: Professional clinical entities named
  • For: Initial synchronous assessment described
  • For: Unlimited clinician contact in program terms
  • For: Compounded status and testimonial limitations disclosed
  • Against: Historical FDA marketing warning without confirmed closeout
  • Against: Current complete cash price not established
  • Against: Additional testing may cost extra
  • Against: Warranty has extensive eligibility conditions

The evidence behind what it sells

Right for

Someone who will scrutinize the proposed prescription and written agreement and values access to follow-up clinicians.

Look elsewhere if

Someone treating the warranty or self-reported marketing data as assurance of success.

Other sellers for weight

Remedy Meds

Frequently asked questions

Is the first clinical review live?
The terms describe an initial synchronous clinician review. Later refill reviews can be asynchronous unless a live session is requested or clinically needed.
Does stopping refill forms stop charges?
No. The terms say the subscription can continue even without a completed refill form or medication shipment.
What did the FDA letter address?
It addressed 2025 marketing claims for compounded semaglutide and tirzepatide. No closeout was confirmed here, and current website changes do not establish one.

Sources

See what Remedy Meds prescribes today

Remedy Meds sets its own prices, plans and the states it serves. Check them before you start.

Written by Paul Hardy from Remedy Meds’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.